Medical device regulation in the European Union, Japan and the United States. Commonalities, differences and challenges

References

• Abelson , R. and Petersen , M. , 2003 . An operation to ease back pain bolsters the bottom line, too . New York Times , 31 December , pp. A1 and C3 .
   Google Scholar
• AdvaMed-ACCJ , 2007 . Joint written testimony Chuikyo industry hearing , 24 October , Washington , DC : AdvaMed (courtesy Mr Phil Agress) .
   Google Scholar
• Akabayashi , S. , et al. , 2007 . An eight-year follow up study of medical school and general hospital ethics committees in Japan . BMC medical ethics , 29 June , pp. 1 – 9 . Available from: http://www.publicmedcentral.nih.gov [Accessed 29 January 2008] .
   Google Scholar
• Altenstetter , C. 2008 . Medical devices: EU policymaking and the implementation of health and patient safety in France , New Brunswick , NJ : Transaction .
   Google Scholar
• Altenstetter , C. , 2011a . Medical device regulation in Japan. Why Japanese patients do not benefit from innovations . Draft manuscript. Further details available from: [email protected] .
   Google Scholar
• Altenstetter , C. 2011b . Medical device regulation and nanotechnologies: determining the role of patient safety concerns in policymaking . Law and policy , 33 ( 2 ) : 227 – 255 . doi: 10.1111/j.1467-9930.2010.00337.x
   Web of Science ®Google Scholar
• Angell , M. , 2010 . The FDA. This agency can be dangerous . The New York Review of Books , 30 September .
   Google Scholar
• Arakawa , Y. , 2007 . Role of academic and government leadership in clinical research infrastructure – Japan Academic Perspective . Presentation at HBD West Meeting at Duke University , Durham , NC , 11 January .
   Google Scholar
• Banta , D. 1994 . Health care technology and its assessment in eight countries: Australia, Canada, France, Germany, Netherlands, Sweden, United Kingdom, United States . Health policy , 30 ( 1–2 ) : 1 – 42 . doi: 10.1016/0168-8510(94)00683-6
   Web of Science ®Google Scholar
• Barnett Educational Services , 2005 . The global GCP compliance report 2006: US. EU, and Japan . Waltham , MA : Barnett Educational Services .
   Google Scholar
• Bartlett-Foote , S. 1992 . Managing the medical arms race , Berkeley , CA : The University of California Press .
   Google Scholar
• Carpenter , D. 2010 . Reputation and power. Organizational image and pharmaceutical regulation of the FDA , Princeton , NJ : Princeton University Press .
   Google Scholar
• Carpenter , D. and Angell , M. , 2010 . To the Editor: How dangerous is the FDA: an exchange . The New York Review of Books , 28 October , pp. 49 – 50 .
   Google Scholar
• Caruso , D.B. 2009 . US has no good system to track medical implants . Associated Press . 5 October .
   Google Scholar
• Center for Devices and Radiological Health , 2006 . Ensuring the safety of marketed medical devices. CDRH's medical device postmarket safety program , 18 January .
   Google Scholar
• Chai , J. 2000 . Medical device regulation in the United States and the European Union: a comparative study . Food and drug law journal , 55 : 57 – 80 .
   Web of Science ®Google Scholar
• Challoner , D. 2011a . IOM. Medical devices and the public's health. The FDA 510(k) clearance process at 35 years , Washington , DC : The National Academies Press .
   Google Scholar
• Challoner , D. , 2011b . Chair of the Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process . Letter to Dr Shuren, Director. CDRH, dated July 20 .
   Google Scholar
• Chatterje , A.K. 2008 . Physician–industry cooperation in the medical device industry . Health affairs , 27 : 1532 – 1543 . doi: 10.1377/hlthaff.27.6.1532
   Web of Science ®Google Scholar
• Cheng , M. , 2007 . An overview of medical device policy and regulation . HNP Brief 8 . Washington , DC : World Bank
   Google Scholar
• Clinica ., 2008 . World medical technology news , 1299 , 11 .
   Google Scholar
• Cohen , A.B. and Hanf , R.S. 2004 . Technology in American health care. Policy directions for effective evaluation and management , Ann Arbor , MI : The University of Michigan Press .
   Google Scholar
• Curfman , G.D. and Redberg R. , 2011 . Medical devices – balancing regulation and innovation . New England journal of medicine , 365 ; 11 , 975 – 977 . doi: 10.1056/NEJMp1109094
   Web of Science ®Google Scholar
• Demske , G. , 2008 . Testimony of Gregory E. Demske . Senate Special Committee on Aging. Hearing , 27 February .
   Google Scholar
• Deyo , A.R. , 2008 . Don't be too eager to try the latest gadgets . Seattle Times , 5 June , pp. 1 – 3 .
   Google Scholar
• Dolata , U. , 2007 . Technik und sektoraler Wandel: Technologische Eingriffstiefe, sektorale Adaptionsfähigkeit und soziotechnische Transformationsmuster . MPIfG Discussion Paper 07/3 . Cologne : Max Planck Institute for the Study of Societies .
   Google Scholar
• Dorbeck-Jung , B.R. et al. , eds , 2011 . Governing nanomedicine: lessons from within, and for, the EU medical technology regulatory framework. Guest editors’ introduction . Law and policy , 33 ( 2 ), 215 – 224 .
   Web of Science ®Google Scholar
• Drezner , D.W. 2007 . All politics is global. Explaining international regulatory regimes , Princeton , NJ : Princeton University Press .
   Google Scholar
• Eaton , M.E. and Kennedy , D. 2007 . Innovation in medical technology. Ethical issues and challenges , Baltimore , MD : The Johns Hopkins University Press .
   Google Scholar
• Eno , H. , 2006a . Postmarket obligations in Japan . In : AdvaMed, sponsor, Japan submission workshop , Tokyo , 8–9 November .
   Google Scholar
• Eno , H. , 2006b . How to comply with Japan's regulatory requirements: strategies for success . In : Advamed, sponsor, Japan submission workshop , Tokyo , Japan , 8–9 November .
   Google Scholar
• European Commission , 2012 . Proposal for a Regulation of the European Parliament and of the Council on medical devices, and amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No1223/2009 . Brussels , 26.9.2012 COM(2012) 542 final.
   Google Scholar
• Faulkner , A. , ed ., 2012 . Steering biomedicine: the regulatory dynamics of therapeutic technologies . Innovation – the European journal of social science research . 25 ( 4 ).
   Google Scholar
• Finn , K. , 2010 . Globalization drives device regulation . RAJ Devices , 13 January , pp. 1 – 9 .
   Google Scholar
• Food and Drug Administration , Regulatory science in FDA's Center for Devices and Radiological Health. A vital framework for protecting and promoting public health . UCM 274162. Created 26 September 2011; modified 5 October 2011 .
   Google Scholar
• Garcia , J. and Auclair , Ph. , 2008 . Overview of GHTF GS2 and NCAR . Available from: http://www.ghtf.org/2008-03-05%20Overview20%of%20GHTF%20SG2%20and%20NCAR [Accessed 14 June 2011] .
   Google Scholar
• General Accounting Office , 2009a . Action needed to improve timelines and enhance scope of FDA's debarment and disqualification process for medical product investigators . GAO-09-807 , 25 September .
   Google Scholar
• General Accounting Office , 2009b . FDA faces challenges meetings its growing medical product responsibilities and should develop complete estimates of its resource needs . GAO-09-581 , 19 June .
   Google Scholar
• General Accounting Office , 2009c . Shortcomings in FDA's premarket review, postmarketing surveillance and inspections of device manufacturing establishments . GAO-09-370T , 18 June .
   Google Scholar
• Global Harmonization Task Force . GHTF/SG2 N80R9 . Available from: www.ghtf.org [Accessed 16 June 2011] .
   Google Scholar
• Global Harmonization Task Force , 2008 . GHTF retrospective assessment. Key findings and recommendations . Presented to the GHTF Steering Committee by the GHTF Retrospective Study Team . Available from: www.ghtf.org [Accessed 17 June 2011] .
   Google Scholar
• Grande , E. and Zangl , B. , 2010 . Varieties of preventive governance in world risk society . Ludwig Maximilian Universität München, Geschwister Scholl Institut für Politische Wissenschaft (draft, courtesy Grande) .
   Google Scholar
• Greenberg , E.G. 2007 . Science for sales. The perils rewards, and delusions of campus capitalism , Chicago , IL : University of Chicago Press .
   Google Scholar
• Gropp , M. , 2007 . Optimal use of experience gained in post-marketing surveillance in medical device regulatory policy. Some personal reflections . Presentation at the Global Harmonization Task Force conference , Washington , DC , 4 October .
   Google Scholar
• Hall , P.A. and Soskice , D. , 2001 . Varieties of capitalism: The institutional foundations of comparative advantage . Oxford : Oxford University Press .
   Google Scholar
• Hamburg , M.A. and Sharfstein , J.M. 2009 . The FDA as a public health agency . The New England journal of medicine , 360 ( 24 ) : 2493 – 2495 . doi: 10.1056/NEJMp0903764
   PubMed Web of Science ®Google Scholar
• Hancher , L. and Moran , M. , 1989 . Capitalism, culture and regulation . Oxford : Oxford University Press .
   Google Scholar
• Hodges , Chr. 2005 . European regulation of consumer product safety , Oxford : Oxford University Press .
   Google Scholar
• Ikegami , N. and Campbell , J.C. 1998 . The art of balance. Maintaining Japan's low-cost, egalitarian system , Cambridge : Cambridge University Press .
   Google Scholar
• Ikegami , N. and Campbell , J.C. 2008 . Dealing with the medical axis of power: the case of Japan . Health economics, policy and law , 3 ( 2 ) : 107 – 113 . doi: 10.1017/S1744133108004428
   Google Scholar
• Institute of Medicine , 2000 . To err is human. Building a safer health system . Washington , DC : National Academy Press .
   Google Scholar
• Institute of Medicine , 2001a . Crossing the quality chasm: new health systems for the 21st century . Washington , DC : National Academy Press .
   Google Scholar
• Institute of Medicine , 2001b . Responsible research. Protecting participants . Washington , DC : Institute of Medicine .
   Google Scholar
• Institute of Medicine , 2011a . Medical devices and the public's health. The FDA 510(k) clearance process at 35 years . Washington , DC : The National Academies Press .
   Google Scholar
• Institute of Medicine , 2011b . Public health effectiveness of the FDA 510(k) clearance process. Measuring post-market performance and other select topics . Workshop report . Washington , DC : The National Academies Press .
   Google Scholar
• Institute of Medicine , 2010 . Public health effectiveness of the FDA 510(k) clearance process. Balancing patient safety and innovation , Wizeman , T. , Workshop report . Washington , DC : The National Academies Press .
   Google Scholar
• Ishikawa , H. , 2009 . Realizing the value of technology . In : 12th conference of the GHTF , Toronto , 12–14 May .
   Google Scholar
• Jonsson , H.D. , et al. , eds , 2002 . European collaboration for health technology assessment-developing an assessment network . International journal of technology assessment in health care , 18 ( 2 ), 213 – 455 .
   Google Scholar
• Jordana , J. and Levi-Faur , D. , 2004 . The politics of regulation: institutions and regulatory reforms for the age of governance . Cheltenham : Edward Elgar .
   Google Scholar
• Jordana , J. and Sancho , D. , 2004 . Regulatory designs, institutional constellations and the study of the regulatory state . In : J. Jordana and Levi-Faur The politics of regulation: institutions and regulatory reforms for the governance age . Cheltenham : Edward Elgar , chapter 13 .
   Google Scholar
• Kahan , J.S. 2009 . Medical device development. Regulation and law , Needham , MA : Barnett International .
   Google Scholar
• Kaiser , R. 2008 . High-Tech policies: Institutionelle Determinanten staatlicher Innovationspolitik im Internationalen Vergleich . Zeitschrift für Politikwissenschaft , 1 : 5 – 24 .
   Google Scholar
• Kelemen , R.D. 2011 . Eurolegalism. The transformation of law and regulation in the European Union , Cambridge , MA : Harvard University Press .
   Google Scholar
• Kramer , D.B., Xu , S. and Kesselheim , A.S. , 2012 . Regulation of medical devices in the United States and European Union . New England journal of medicine , 336 , 1 March . Available from: www.nejm.org [Accessed 5 April 2010] .
   Google Scholar
• Kruger , K. 2005 . “ The medical device sector ” . In The business of healthcare innovation , Edited by: Burns , L.P. 271 – 321 . Cambridge : Cambridge University Press .
   Google Scholar
• Leflar , R.B. 2009 . Unusual deaths, criminal sanctions, and medical quality improvement in Japan . Yale journal of health policy, law and ethics , 9 ( 1 ) : 101 – 136 .
   Google Scholar
• Levi-Faur , D. , 2008 . Presentation. (Re)Regulation in the wake of neoliberalism. Consequences of three decades of privatization and market liberalization . ECPR regulation & governance. Second biennial conference of the Standing Group on Regulation and Governance , Utrecht , 5–7 June 2008 .
   Google Scholar
• Levi-Faur , D. , 2010 . Regulation and regulatory governance . Jerusalem Papers in Regulation and Governance, Working Paper, no. 2 , February , 1 – 47 .
   Google Scholar
• Lobmayr , B. 2010 . An assessment of the EU approach to medical device regulation against the backdrop of the U.S. system . European journal of risk regulation , 2 : 39 – 51 .
   Google Scholar
• Lobmayr , B. , 2011 . Innovation and regulation in high-risk medical device markets . Unpublished thesis . University of Southern Australia .
   Google Scholar
• Ludwig , E.J. , Chairman of the Board, AdvaMed , 2006 . Testimony before the International Trade Commission on Medical Devices and Equipment: competitive conditions affecting US trade in Japan and other principal foreign markets , 11 July . Investigation no. 332–474 .
   Google Scholar
• Maisel , W.H. , 2008a . Medical device safety and the FDA. (Correspondence.) New England journal of medicine , 359 , 88 – 89 . Available from: www.nejm.org [Accessed 24 March 2012] .
   Web of Science ®Google Scholar
• Maisel , W.H. , 2008b . Semper fidelis – consumer protection for patients with implanted medical devices . New England journal of medicine , 358 ( 10 ), 985 – 987 . Available from: www.nejm.org [Accessed 24 March 2012] . doi: 10.1056/NEJMp0800495
   PubMed Web of Science ®Google Scholar
• Maisel , W.H. and Kono , T. 2010 . Improving the security and privacy of implantable medical devices . New England journal of medicine , 362 ( 13 ) : 1164 – 1166 . doi: 10.1056/NEJMp1000745
   Web of Science ®Google Scholar
• Marmor , Th.R. , Freeman , R. and Okma , K. 2005 . Comparative perspectives and policy learning in the world of health care . Journal of comparative policy analysis , 7 ( 4 ) : 331 – 348 . doi: 10.1080/13876980500319253
   Google Scholar
• Maxwell , A. , 2011a . Recast will seek better to define scope of EU medtech directives . Available from: http://www.rajdevices.com [Accessed 3 May 2011] .
   Google Scholar
• Maxwell , A. , 2011b . European Commission spells out recast aims . Available from: http://www.rajdevices.com [Accessed 5 May 2011] .
   Google Scholar
• Maxwell , A. and Finn , K. , 2010 . EU-wide guidance on severe adverse events , 27 September, 2010 . Available from: http://www.rajdevices.com [Accessed 29 September 2010] .
   Google Scholar
• McElhatton , J. , 2008 . Lobbying of the industry . Available from: http://washingtontimes.com/apps/pbcs.dll/article?AID=/200318NATION/3846868095/1 [Accessed 18 March 2008] .
   Google Scholar
• Medical Technology Leadership Forum , 2007 . Forum report. Special program. A leadership dialogue for stakeholders and policy leaders from Japan, and the United States , Karuizawa , 21–23 April .
   Google Scholar
• Mitsumori , Y. , 2007 . The latest regulatory environment. News from Japan . Medical product outsourcing MPO magazine . Available from: http://www.mpo-mag.com/articles/2007 [Accessed 19 November 2007] .
   Google Scholar
• Moss , D. 2002 . When all else fails. Governments as the ultimate risk manager , Cambridge , MA : Harvard University Press .
   Google Scholar
• Mossialos , E. and McKee , M. 2002 . EU law and the social character of health care , Brussels : Peter Lang .
   Google Scholar
• Naidu , B.D. 2009 . Biotechnology and nanotechnology. Regulation under environmental, health, and safety laws , New York : Oxford University Press .
   Google Scholar
• Newberger , J.D. , 2011 . New guidance from the FDA may mean just one thing for medical device manufacturers – more 510(k) , 1 August 2011 . Available from: http://rajdevices.com [Accessed 8 January 2011] .
   Google Scholar
• Nottage , L. 2005 . “ Comparing product safety and liability law in minamata to mad cows – and Mitsubishi ” . In Product liability in comparative perspective , Edited by: Fairgrieve , D. 334 – 340 . Cambridge : Cambridge University Press .
   Google Scholar
• OECD , 1998 . Regulation . Paris : OECD .
   Google Scholar
• OECD , 2010 . Health at a glance: Europe 2010 . Available from: www.oecd.org [Accessed 17 December 2010] .
   Google Scholar
• OECD , 2012 . Recommendation of the Council on regulatory policy and governance . Paris : OECD . Available from http://www.oecd.orgdocumentprint [Accessed 5 April 2012] .
   Google Scholar
• Ohki , T. , 2007 . Advanced medical devices saves lives: vascular surgery . Presentation at A leadership dialogue for stakeholders and policy leaders from Japan and the United States , Karuizawa , 21–23 April .
   Google Scholar
• Okie , S. , 2010 . Reviving the FDA . New England journal of medicine , 363 ( 16 ), 1492 – 1494 . Available from: www.nejm.org [Accessed 10 September 2011] . doi: 10.1056/NEJMp1009686
   Web of Science ®Google Scholar
• Olsen , P. and Peters , D.G. 1996 . Lessons from experience. Experiential learning in administrative reforms in eight democracies , Oslo : Scandinavian University Press .
   Google Scholar
• Pammolli , F. et al. , 2005 . Medical devices. Competitiveness and impact on health expenditure . Study prepared for the Directorate Enterprise of the European Commission . Rome : Competitiveness, Markets and Regulation and University of Florence .
   Google Scholar
• Pharmaceutical and Medical Devices Agency , 2007 . Profile of services. Fiscal year 2007 . Available from: http://www.pmda.go.jp./english/html [Accessed 28 October 2010] .
   Google Scholar
• Pharmaceutical and Medical Devices Agency , 2010 . Profile of services. Fiscal year 2010 . Available from: http://www.pmda.go.jp./english/html [Accessed 21 March 2011] .
   Google Scholar
• Pierson , P. 2004 . Politics in time. History, institutions, and social analysis , Princeton , NJ : Princeton University Press .
   Google Scholar
• Resnic , F.S. and Normand , S.-L.T. 2012 . Postmarketing surveillance of medical devices – filling in the gap . New England journal of medicine , 366 ( 10 ) : 875 – 877 . doi: 10.1056/NEJMp1114865
   PubMed Web of Science ®Google Scholar
• Rodwin , M.A. 2011 . Conflicts of interest and the future of medicine. The United States, France and Japan , New York : Oxford University Press .
   Google Scholar
• Rosenbloom , J. 2007 . Global trends in reimbursement of medical technology. Clinical Reports , Abingdon : Informa .
   Google Scholar
• Saltman , R.B. , Busse , R. and Figueras , J. 2004 . Social health insurance systems in western Europe , Buckingham : Open University Press .
   Google Scholar
• Schmitter , Ph.C. 1996 . Governance in the European Union , London : Sage .
   Google Scholar
• Schultz , D. , 2006 . New and emerging technologies. Balancing safety and uncertainty . Presentation at the GHTF 2006 conference , Lübeck , Germany , 28–30 June .
   Google Scholar
• Snowbeck , Chr. , 2008 . Device makers pump up lobbying . Available from: http://www.twincities.com/ci_8643904?source-rss [Accessed 21 March 2008] .
   Google Scholar
• Steinmo , S. , Thelen , K. and Longstreth , F. , 1992 . Structuring Politics. Historical Institutionalism in Comparative Analysis . Cambridge : Cambridge University Press .
   Google Scholar
• Tan , T. , 2012 . Japans mulls separate regulatory structure for medical devices . Available from: http://www.rajpharma.com [Accessed 7 March 2012] .
   Google Scholar
• Thelen , K. 2004 . How institutions evolve: The political economy of skills in Germany, Britain, the United States and Japan , Cambridge : Cambridge University Press .
   Google Scholar
• The Regulatory Affairs Journal Devices , 2008–2010 , thereafter 2010–2012 The Regulatory Affairs Medtech . Available from: http://www.rajdevices.com
   Google Scholar
• United States International Trade Commission , 2007 . Medical devices and equipment: competitive conditions affecting U.S. trade in Japan and other foreign markets . Investigation no. 332–474. US ITC Publication 3909 .
   Google Scholar
• Verhoerst , K.S. et al. , 2012 . Government agencies: practices and lessons from 30 countries . Basingstoke : Palgrave Macmillan .
   Google Scholar
• Voelker , R. , 2011 . FDA ponders regulation and innovation . Journal of the American Medical Association , 35 ( 15 ), 1523 – 1524 . Available from: http://www.Jama.ama-assn.org [Accessed 25 March 2012] .
   Google Scholar
• Vogel , D. 2012 . The politics of precaution. Regulating health, safety, and environmental risks in Europe and the United States , Princeton , NJ : Princeton University Press .
   Google Scholar
• West , D.M. 2007 . Biotechnology across national boundaries. The science–industrial complex , London : Palgrave .
   Google Scholar
• Wiener , J.R. and Rogers , M.D. 2002 . Comparing precaution in the United States and Europe . Journal of risk research , 5 ( 4 ) : 317 – 349 . doi: 10.1080/13669870210153684
   Google Scholar
• Working Group on New and Emerging Technologies in Medical Devices , 2007 . Report on nanotechnology. Findings and recommendations , 27 July . Available from: http://ec.europa.eu.enterprise/medical_devices/net/entr-2007-net-wg-report-nano-final.pdf [Accessed 28 June 2009] .
   Google Scholar
• Wright , E. and Datlof , S. 2010 . Adverse event reporting in the EU and the USA: similarities and differences . Journal of medical device regulation , 7 ( 3 ) : 14 – 22 .
   Google Scholar
• Yeo , A. , 2010 . The regulators’ chance to catch up with science . RAJ devices , 29 September 2010 . Available from: http://www.rajdevices.com [Accessed 30 September 2010] .
   Google Scholar
• Yeo , A. , 2012 . Commission intends to “move from directives to regulations” for EU medtech sector , 26 June . Available from http://www.rajpharma.com [Accessed 1 July 2012] .
   Google Scholar
• Zuckerman , D. 2008 . Do conflicts of interest undermine FDA approval decisions? . RAJ Devices , 16 ( 5 ) : 309 – 310 .
   Google Scholar
• Zuckerman , D. , 2011 . Testimony. Hearing before the Special Committee on Aging . US Senate, First Session, 13 April 13 .
   Google Scholar
• Zuckerman , D. , Brown , P. and Nissen , E. , 2011 . Medical device recalls and the FDA approval process . Stanford University Medical Center . Available from: http://www.archintenmed [Accessed 21 April 2011] .
   Google Scholar